# PyroGenesis Canada Inc.: financial statements, quarterly

PYRGF · OTC · CIK 1743344 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pyrgf.md) · [Financials](/companies/pyrgf/financials.md) · [Filings](/companies/pyrgf/filings.md) · [Insiders](/companies/pyrgf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pyrgf/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2018-12-31) | period not labelled (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | [18.1](/filings/0001410578-22-000806.md) | [12.2](/filings/0001410578-22-000806.md) | not reported |
| Current assets | $m | not reported | [1.3](/filings/0001104659-21-049824.md) | [25.3](/filings/0001410578-22-000806.md) | [38.8](/filings/0001562762-23-000149.md) | [27.4](/filings/0001562762-23-000149.md) |
| Total assets | $m | not reported | [9.6](/filings/0001104659-21-049824.md) | [74.5](/filings/0001410578-22-000806.md) | [69.8](/filings/0001562762-23-000149.md) | [47.7](/filings/0001562762-23-000149.md) |
| Current liabilities | $m | not reported | [11.8](/filings/0001104659-21-049824.md) | [11.5](/filings/0001410578-22-000806.md) | [24.8](/filings/0001562762-23-000149.md) | [25.8](/filings/0001562762-23-000149.md) |
| Total liabilities | $m | not reported | [15.7](/filings/0001104659-21-049824.md) | [15.1](/filings/0001410578-22-000806.md) | [29.0](/filings/0001562762-23-000149.md) | [30.8](/filings/0001562762-23-000149.md) |
| Shareholders' equity | $m | [(1.0)](/filings/0001104659-21-049824.md) | [(6.1)](/filings/0001410578-22-000806.md) | [59.4](/filings/0001562762-23-000149.md) | [40.8](/filings/0001562762-23-000149.md) | [16.9](/filings/0001562762-23-000149.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 173,580,395 at 2022-12-31, from the cover of the [40-F filed 2023-03-31](/filings/0001562762-23-000149.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.